The FDA's Center for Drug Evaluation and Research will hold a public workshop Oct. 30 at its White Oak campus in Silver Spring, Md., to help the rare disease community better understand what the agency needs to enhance drug development. The workshop will include presentations on engaging with the FDA and on strategies, tools and best practices for drug development for rare diseases.